- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Cytogen reports on Quadramet status
Radiopharmaceutical firm Cytogen announced this month that it is in late-stage negotiations with potential marketing partners for Quadramet, the company’s bone cancer palliative agent. Cytogen is working with former marketing partner Du Pont
Radiopharmaceutical firm Cytogen announced this month that it is in late-stage negotiations with potential marketing partners for Quadramet, the companys bone cancer palliative agent. Cytogen is working with former marketing partner Du Pont Pharmaceuticals to expedite the changeover, according to the company. North Billerica, MA-based Du Pont will continue to manufacture Quadramet.
The two companies initiated an interim agreement June 2 in which they determined that Du Pont would identify marketing partner candidates for Cytogen (SCAN Special Report 6/98). The agreement has been extended through the end of this month, pending the final selection of a new partner and the completion of Cytogens marketing arrangements with Du Pont. Cytogen has taken over the identification and selection of candidates as the process continues.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
